Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Neoplasms × neratinib × Clear all

Phase

Status

Completed 21 Recruiting 6 Terminated 5 Withdrawn 2 Active not recruiting 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Breast Cancer 1

Interventions

Cyclophosphamide 77 Docetaxel 68 Capecitabine 63 Trastuzumab 59 Paclitaxel 51 Epirubicin 47 Tamoxifen 46 Letrozole 42 pyrotinib 39 Fulvestrant 35 Doxorubicin 35 Vinorelbine 33 Radiotherapy 31 Carboplatin 31 exemestane 27 Anastrozole 27 Neoadjuvant Therapy 24 Drug Therapy 22 Fluorouracil 21 palbociclib 20 Chemotherapy, Adjuvant 19 Exercise 18 Bevacizumab 18 Goserelin 16 Cisplatin 16 pertuzumab 15 liposomal doxorubicin 15 Gemcitabine 14 Blood Specimen Collection 14 Mammography 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03812393 2023-12-18

FACT-2

West Cancer Center

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡